InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner...

InnovationRx, a Prescription Adherence Solutions Company, and InforMedix
Partner to Market and Sell End-to-End Medication Adherence Solutions

ROCKVILLE, Md. and NEWTON, Mass., April 17 /PRNewswire-FirstCall/ --
InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX), providing
Med-ePhone(TM), Med-eMonitor(TM), and Med-eXpert(TM) Systems to improve
medication adherence and health status monitoring, and InnovationRx, a
provider of prescription medication adherence solutions, announced an
agreement to market and sell a combined product line to a broad spectrum of
Federal and State Governmental Agencies, insurance companies, health plans,
managed care companies, disease management organizations, and other related
private and public industry organizations and plans.
InnovationRx, the healthcare division of Innovation Group, employs an
inter-disciplinary, multi-modal methodology to assess and improve medication
adherence, which provides clinical evaluation, customized interventions and
progress reports. Their services, developed in a research grant partnership
with Northeastern University School of Pharmacy, are anchored by proprietary
medication adherence risk-assessment instruments and intervention plans,
combined with interactive Web-based tools and live pharmacists in call
centers. These licensed pharmacists, trained in motivational interviewing and
compliance, provide patients with personalized, one-to-one support and
consultation. Innovation Group is a global company with revenues in excess of
$250 million and is focused on providing risk management business solutions to
various industries and marketplaces throughout the world.
The companies are collaborating to create discrete combinations of their
respective products and services that address differing levels of adherence
risk among low risk, medium risk, and high risk populations. Specifically
combined product and service offerings will be developed, marketed and sold at
specific price points. The combinations will be designed to provide the right
mix of products and services to best achieve improved medication adherence,
health outcomes, and sponsor return-on-investment for each level of
non-adherence risk. It is estimated that medication non-adherence, defined as
the failure of patients to take medications as prescribed, results in $300
billion of annual costs to the U.S. healthcare system, $100 billion of which
is hospital costs. In addition, it is estimated that non-adherence causes 40%
of nursing home admissions, and is responsible for between 10% and 28% of all
hospital admissions.
Sean Teare, President of InnovationRx stated, "We are thrilled to be
working with InforMedix to uniquely combine our proprietary assessment and
behavioral modification techniques and technologies, anchored in
pharmacist-based call centers, with InforMedix's real-time prompting,
monitoring, reporting, and automatic outbound alerting when patients miss
their medications, or their health status is declining. Med-eXpert's detailed
Web-enabled reports for each patient, graphically depicting their reasons for
non-adherence (e.g. side effects, ran out of medications, change in doctors'
orders, etc.), will enhance the consulting effectiveness of our pharmacists.
Bruce A. Kehr, M.D., chairman and Chief Executive Officer of InforMedix
commented "What is really exciting about our plans with InnovationRx is that
through combining their products and services with our own, we offer the
marketplace an end-to-end solution that first assesses risk of patient
non-adherence, and then assigns that patient exactly what products and
services they need to optimize adherence and health. The addition of risk
assessment algorithms, and pharmacist-based call centers receiving real-time
adherence and health status data from our Med-eXpert database, from patients
using our Med-ePhone or Med-eMonitor, powerfully completes a comprehensive
medication adherence solution that is unique to the marketplace. We believe
that by working together with InnovationRx, backed by the global reach of
their parent, Innovation Group, we can significantly increase our visibility
and revenues."
About InnovationRx
InnovationRx is based in Newton, MA. The company provides prescription
medication adherence solutions. Built on a review of the literature and
research related to factors affecting patient adherence and successful ways to
intervene, InnovationRx employs an inter-disciplinary, multi-modal methodology
that provides clinical evaluation, customized interventions and progress
reports. For more information, visit http://www.innovationrx.com
About Innovation Group
Innovation Group (LSE: TiG) is one of the leading solution providers to
the global insurance industry through the development of a flexible
combination of specialized business process outsourcing, supply chain
management and technology solutions. Our partnerships give clients access to
proven, leading-edge technology, world-class insurance expertise and global
delivery capabilities. Through our work with major global brands we've
achieved an impressive track record of turning business strategy into
operational reality. For more information, visit
http://www.innovation-group.com
About Northeastern University School of Pharmacy
A leader in interdisciplinary research, Northeastern University's
signature cooperative education program, one of the largest and most
innovative in the world, is ranked among the top 100 best universities in the
nation by U.S. News & World Report. Northeastern takes pride in its
translational research approach and in its partnerships with several
Boston-area teaching hospitals, community health centers, community and
hospital pharmacies, and medical research facilities. For more information,
visit http://www.northeastern.edu/bouve/pharmacy/
About InforMedix
InforMedix, Inc., "The Medication Adherence Solution," is based in
Rockville, Maryland. The Company has brought to market its Med-eXpert System
for consumer product and disease management markets, which use Med-ePhone and
Med-eMonitor units to deliver peace-of-mind, improved independent living, and
better health outcomes to patients and their loved ones. The Med-ePhone(TM)
System (in testing) prompts, monitors and records medication adherence and
health status assessment delivered to patients over mobile phones and
landlines using Interactive Voice Response Systems (IVRS), combined with 24/7
monitoring. The Med-eMonitor System ("Medication, Safe and Easy"(TM))
integrates a portable patient-interactive "smart pillbox", hardware, software,
and 24/7 monitoring. Both products are designed to enable chronically ill
patients and their loved ones, professionals in disease management programs,
and medical researchers to efficiently monitor and manage medication and care
plan adherence, clinical response, and drug safety. For more information,
visit http://www.informedix.com
Safe Harbor Statement
This press release may contain forward looking statements that involve
risks and uncertainties, including statements regarding our business strategy
and development plans, expectations regarding increased sales and/or revenues,
plans for entering into new businesses, anticipated sources and uses of funds
and other statements regarding our plans, objectives, expectations and
intentions that are not historical facts. Because these forward-looking
statements involve risks and uncertainties, actual results could differ
materially from those discussed in this press release. These risks and
uncertainties are described in greater detail in the reports that we file with
the Securities and Exchange Commission. Our actual results, performance or
achievements may vary materially from those expressed or implied in any
forward-looking statements. All forward-looking statements reflect our beliefs
and expectations as of the date of this press release and should not be relied
upon as representing our views as of any subsequent date. While we may elect
to update these forward-looking statements publicly at some point in the
future, we specifically disclaim any obligation to do so, whether as a result
of new information, future events or otherwise.
SOURCE InforMedix Holdings, Inc.

Kate Kimmins, InforMedix, +1-301-984-1566, kate.kimmins@informedix.com; or
Sean Teare, Innovation Rx, +1-617-886-2000, teares@innovationrx.com; or
Meaghan Kenagy, Innovation Group, +1-617-319-6032,
kenagym@us.innovation-group.com; or Tom Dean of Murdock Capital Partners,
+1-212-421-2545, murdockcapital@gmail.com